PHARMASENS
PharmaSens is a focussing on the development of next-generation devices for diabetes care. Their innovative, user-friendly, patch-type devices for precise administration of insulin and for continuous glucose monitoring are designed to improve the lives of people with diabetes. These devices under broad patent protection, are extremely easy to use, painless and tubeless, and designed for low costs of manufacturing.
PHARMASENS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Reinach, Aargau, Switzerland
Country:
Switzerland
Website Url:
http://www.pharmasens.com
Total Employee:
11+
Status:
Active
Contact:
+41 61 711 0283
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Euro Google Maps Google Maps API Sectigo SSL Sectigo Domain SSL PostalAddress Schema
Similar Organizations
Ascendas Genomics
Ascendas is focused on the development of next-generation genetic testing reagents and systems.
Easypharm
Easypharm is today fully focusing on the Consumer Healthcare business and distribution in Austria.
Lucilia Pharma
Lucilia Pharma is a drug discovery company focused on exploiting the beneficial molecular properties of entities excreted/secreted.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Okairos
Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.
Pharmacure Health Care International AB
Pharmacure focuses on the development of new drug to improve the therapeutic the enhancing nasal comfort of our patients.
Swiss Rockets
Swiss Rockets focuses on the development of new treatment therapies and clinical drugs for cancer patients.
VitrOmics Healthcare Holding BV
VitrOmics Healthcare Holding BV is focusing on the development of new diagnostic products.
Official Site Inspections
http://www.pharmasens.com
- Host name: nova.metanet.ch
- IP address: 80.74.156.100
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "PharmaSens"
We are PharmaSens
We at PharmaSens are devoted to simplifying diabetes management. We are passionate about technology bringing more people with diabetes towards better treatment and a life with โฆSee details»
PharmaSens | Simplified diabetes management
PharmaSens is developing three different products to simplify diabetes management for as many people as possible using insulin. Three insulin patch pumps with a lot in common. All three โฆSee details»
PharmaSens - Crunchbase Company Profile & Funding
PharmaSens is a focussing on the development of next-generation devices for diabetes care. Their innovative, user-friendly, patch-type devices for precise administration of insulin and for continuous glucose monitoring are designed โฆSee details»
PharmaSens AG - LinkedIn
We at PharmaSens are devoted to simplifying diabetes management. We are passionate about technology bringing more people with diabetes towards better treatment and a life with increased freedom ...See details»
PharmaSens - Products, Competitors, Financials, Employees, โฆ
Gabbay brings a wealth of research and peer-reviewed publication experience to PharmaSens at a time when the organization is undertaking extensive clinical study of its technology. The โฆSee details»
PharmaSens Company Profile 2024: Valuation, Funding โฆ
PharmaSens General Information Description. Developer of pharma device intended to deliver insulin safely for diabetes patients. The company designs and develops devices integrated with continuous glucose monitoring as well as โฆSee details»
PharmaSens Successfully Submits FDA Approval Application for ...
Pharmasens AG +41 61 711 02 83 Aarbergstrasse 46 [email protected] 2502 Biel/Bienne www.pharmasens.com Switzerland About PharmaSens PharmaSens AG, a privately owned โฆSee details»
PharmaSens Earns ISO 13485 Certification and Drives Diabetes โฆ
Oct 11, 2023 PharmaSens remains well-aligned for an FDA submission slated for late 2023 . Biel/Bienne (Switzerland), November 10, 2023 . PharmaSens AG, a privately owned Swiss โฆSee details»
PharmaSens - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 The intellectual property of PharmaSens includes 25 registered patents primarily in the ' Medical Or Veterinary Science; Hygiene ' category, according to IPqwery. Additionally, โฆSee details»
PharmaSens - Contacts, Employees, Board Members, Advisors
PharmaSens is a company focussing on the development of next-generation devices for diabetes care.See details»
PharmaSens: Simplifying diabetes management - We โฆ
PharmaSens are leading the way in Diabetes Care management, niia essential Insulin Patch Pump has ISO 13485 Certification and is set for an FDA submission at the end of the year. We are Human partnered with PharmaSens to support โฆSee details»
PharmaSens adds former ADA leaders, medtech veterans to board
Nov 6, 2024 PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.. Gabbay joins the board of the Swiss company after โฆSee details»
PharmaSens AG - YouTube
We at PharmaSens are devoted to simplifying diabetes management. We are passionate about technology bringing more people with diabetes towards better treatment and a life with โฆSee details»
PharmaSens seeks FDA approval for new insulin pump - Medical โฆ
Jan 2, 2024 PharmaSensโs semi-reusable concept of the insulin pump system aligns with cost-efficiency and sustainable design, meeting the demand for environmentally friendly products. โฆSee details»
Insulin Delivery Innovator PharmaSens Appoints Robert Gabbay, โฆ
Nov 6, 2024 Dr. Gabbay brings a wealth of research and peer-reviewed publication experience to PharmaSens at a time when the organization is undertaking extensive clinical study of its โฆSee details»
PharmaSens Successfully Submits FDA Application for Innovative โฆ
Dec 30, 2023 PharmaSens AG, a Swiss company dedicated to improving access to insulin pump therapy, has successfully submitted its FDA approval application for the revolutionary โฆSee details»
News - Pharmasens
PharmaSens Earns ISO 13485 Certification and Drives Diabetes Care with Innovative niia essential Insulin Patch Pump System Media enquiries To connect with our media relations โฆSee details»
PharmaSens successfully submits FDA approval application for โฆ
Jan 17, 2024 PharmaSens AG has achieved a significant step in its commitment to addressing unmet needs in diabetes management. The company recently submitted its application for โฆSee details»
PharmaSens Successfully Submits FDA Approval Application for
Dec 29, 2023 PharmaSens AG, a privately owned Swiss company, is dedicated to simplifying diabetes management, and broadening the reach of insulin pump therapy. The companyโs โฆSee details»
Our niia insulin patch pumps - Pharmasens
All the products are based on the same matchless technology. From the first niia essential pump, the standalone basal-bolus pump, to the third niia signature pump, the pump with an โฆSee details»